Spire Healthcare Group Plc (LON:SPI) has received a consensus recommendation of “Hold” from the seven ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is GBX 311.50 ($4.17).
A number of analysts have recently commented on the company. Berenberg Bank upgraded Spire Healthcare Group to a “buy” rating and boosted their price objective for the company from GBX 270 ($3.62) to GBX 310 ($4.15) in a research report on Wednesday. Liberum Capital restated a “hold” rating and issued a GBX 270 ($3.62) price objective on shares of Spire Healthcare Group in a research report on Thursday, November 16th. Numis Securities restated an “add” rating and issued a GBX 341 ($4.57) price objective on shares of Spire Healthcare Group in a research report on Monday, October 23rd. Jefferies Group cut their price objective on Spire Healthcare Group from GBX 350 ($4.69) to GBX 259 ($3.47) and set a “hold” rating for the company in a research report on Monday, September 25th. Finally, J P Morgan Chase & Co cut their price objective on Spire Healthcare Group from GBX 376 ($5.04) to GBX 339 ($4.54) and set a “neutral” rating for the company in a research report on Friday, September 15th.
Shares of Spire Healthcare Group (LON SPI) traded down GBX 1.20 ($0.02) during mid-day trading on Thursday, reaching GBX 246.70 ($3.30). The company had a trading volume of 1,409,544 shares, compared to its average volume of 3,600,000. Spire Healthcare Group has a 52 week low of GBX 218.20 ($2.92) and a 52 week high of GBX 369 ($4.94).
The company also recently declared a dividend, which will be paid on Tuesday, December 12th. Investors of record on Thursday, November 16th will be given a dividend of GBX 1.30 ($0.02) per share. This represents a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, November 16th.
In other news, insider Peter R. Bamford purchased 5,000 shares of the company’s stock in a transaction that occurred on Monday, November 27th. The stock was purchased at an average cost of GBX 240 ($3.21) per share, for a total transaction of £12,000 ($16,070.71). Also, insider Justin Ash purchased 84,500 shares of the company’s stock in a transaction that occurred on Thursday, November 23rd. The shares were purchased at an average price of GBX 237 ($3.17) per share, with a total value of £200,265 ($268,200.08). Insiders have purchased 178,600 shares of company stock valued at $41,184,900 over the last quarter.
TRADEMARK VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/11/30/spire-healthcare-group-plc-spi-given-consensus-recommendation-of-hold-by-brokerages.html.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.